Approval · Notice of Compliance 13403 · 2012
ANAFRANIL: Notice of Compliance 13403
Issued June 21, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 13403
- Date
- June 21, 2012
- Company
- Sunovion Pharmaceuticals Canada IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antidepressant; Antiobsessional
Products in this notice
Medicinal ingredients
- CLOMIPRAMINE HCL 10 MG per TAB
- CLOMIPRAMINE HCL 25 MG per TAB
- CLOMIPRAMINE HCL 50 MG per TAB